MedTrace Logo

Evaluation of Immune Signaling Networks in Healthy Human Volunteers

NCT01882582 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2016-05-04

No results posted yet for this study

Summary

The purpose of this study is to better understand whether and to what extent the activity of immune cells in blood varies over time under normal conditions as assessed in healthy subjects. Results of this study will provide the foundation for helping us evaluate changes in immune cell activities in response to surgery and drugs used in anesthesia. The overall purpose of our research is to understand immune health in the context of anesthesia and surgery.

Conditions

  • Normal Immune Cell Function

Sponsors & Collaborators

  • Martin Angst

    lead OTHER

Principal Investigators

  • Martin S Angst, MD · Stanford University SOM

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-08-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01882582 on ClinicalTrials.gov